Patents Represented by Attorney R. E. Carnahan
-
Patent number: 4895939Abstract: Disclosed herein is a novel high .beta.-yield producing novel intermediates of the formula ##STR1## where R.sup.4 is ##STR2## useful in the synthesis of 1-.beta.-alkyl carbapenems.Type: GrantFiled: June 14, 1988Date of Patent: January 23, 1990Assignee: Bristol-Myers CompanyInventors: Alain Martel, Jean-Paul Daris, Jacques Corbeil
-
Patent number: 4772683Abstract: Disclosed herein is a novel process using novel silyl enol ether intermediates of the formula ##STR1## to generate novel azetidione thiolester intermediates of the formula ##STR2## which can be used to form 1-.beta.-alkyl carbapenem antibiotics. It has now been discovered that if the R.sup.4 group is selected from a small group of moieties having the formula: ##STR3## an increased .beta.-yield of up to approximately 100% can be obtained.Type: GrantFiled: February 24, 1986Date of Patent: September 20, 1988Assignee: Bristol-Myers CompanyInventors: Alain Martel, Jean-Paul Daris, Jacques Corbeil
-
Patent number: 4769451Abstract: A novel process is disclosed for converting known 3,4-disubstituted azetidinones to carbapenems. The process proceeds through novel N-substituted intermediates and then cyclizes to the 4-position of the azetidinone to form the carbapenem.Type: GrantFiled: August 15, 1985Date of Patent: September 6, 1988Assignee: Bristol-Myers CompanyInventor: Pierre Dextraze
-
Patent number: 4754030Abstract: The crystalline triethylamine salt of cefbuperazone is stable in the dry state and soluble in water and in aqueous injection vehicles.Type: GrantFiled: February 1, 1985Date of Patent: June 28, 1988Assignee: Bristol-Myers CompanyInventors: Murray A. Kaplan, Robert A. Lipper
-
Patent number: 4699979Abstract: This invention provides novel cephalosporin intermediates, 7.beta.-amino-3-[(Z)-1-propen-1-y1]-3-cephem-4-carboxylic acid and esters thereof having the general formula ##STR1## wherein the configuration of the 3-propenyl group is Z sometimes referred to as cis- and R is hydrogen or a conventional carboxy-protected group, or a physiologically hydrolyzable esterifying group, and acid addition salts thereof and the metal salts of the foregoing substance wherein R is hydrogen. These compounds are useful as intermediates for preparation of orally active cephalosporins.Type: GrantFiled: March 25, 1986Date of Patent: October 13, 1987Assignee: Bristol-Meyers CompanyInventors: Hideaki Hoshi, Jun Okumura, Takayuki Naito, Yoshio Abe, Shimpei Aburaki
-
Patent number: 4282265Abstract: Vegetable oil mixtures are prepared containing from 20-50% by weight of palm oil and quantities of lauric acid oils, oleic acid oils, and linoleic acid oils needed to provide proportions of oleic, palmitic, and linoleic triglycerides similar to proportions in human milk. The mixtures are readily absorbed by normal full-term infants and are well suited as fat ingredients for infant formulas.Type: GrantFiled: January 14, 1980Date of Patent: August 4, 1981Assignee: Bristol-Myers CompanyInventor: Richard C. Theuer
-
Patent number: 4258027Abstract: The invention disclosed provides a multi-fractionable tablet structure initially configurated in a unitary dosage while having readily severable sub-dosage units as components thereof. Score markings are positioned variously about the tablet such as along the top and bottom surfaces thereof. Additionally, score markings may appear along opposite vertical side surfaces of the tablet. Special placement of the score markings readily permits alternatively an accurate equal bisectional or trisectional fracture of the tablet as may be desired for patient consumption.Type: GrantFiled: February 14, 1980Date of Patent: March 24, 1981Assignee: Mead Johnson & CompanyInventors: Michael K. Ullman, Stephen T. David, Claude E. Gallian
-
Patent number: 4254124Abstract: 2-[3-[4-[3-(Trifluoromethyl)phenyl]-1-piperazinyl]propyl]-1,2,4-triazolo[4, 3-a]pyridin-3(2H)-one and its pharmaceutically acceptable acid addition salts are antidepressant agents.Type: GrantFiled: September 24, 1979Date of Patent: March 3, 1981Assignee: Mead Johnson & CompanyInventor: Duane F. Morrow
-
Patent number: 4252815Abstract: 1-Secondary-amino-3-(1-phenyl and substituted phenyl-5-tetrazolyloxy)-2-propanols are new compounds which are useful as cardiovascular agents having vasodilator, antiarrhythmic and .beta.-adrenergic blocking actions.Type: GrantFiled: August 15, 1979Date of Patent: February 24, 1981Assignee: Mead Johnson & CompanyInventors: William E. Kreighbaum, William T. Comer
-
Patent number: 4252806Abstract: 2-[3-[4-Arylpiperazin-1-yl]propyl]-1,2,4-triazolo[4,3-a]-quinolin-3(2H)-one s are antidepressant agents.Type: GrantFiled: September 24, 1979Date of Patent: February 24, 1981Assignee: Mead Johnson & CompanyInventor: Duane F. Morrow
-
Patent number: 4223031Abstract: 6-(1H-Tetrazol-5-yl)thiozolo[3,2-a]pyrimidin-5-ones, 3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-ones, and the corresponding imidazo- and triazolo-pyrimidines, thiones, and imines are useful as antiallergy and antiasthmatic compounds by virtue of their inhibitory action on the immediate hypersensitivity reaction in mammals and relaxant action on the tracheal muscle. Intermediates in the synthesis of these substances from 2-aminoazoles and ethoxy-methylene malononitrile also have smooth muscle relaxant and immediate hypersensitivity reaction inhibitory activity.Type: GrantFiled: May 5, 1978Date of Patent: September 16, 1980Assignee: Mead Johnson & CompanyInventors: Robert R. Covington, Davis L. Temple, Jr., Joseph P. Yevich
-
Patent number: 4215104Abstract: The invention disclosed provides a multi-fractionable tablet structure initially configurated in a unitary dosage while having readily severable sub-dosage units as components thereof. Score markings are positioned variously about the tablet both along the top and bottom surfaces of an approximately rectangular configuration whereas in preferred embodiments thereof, score markings additionally appear along opposite vertical side surfaces of the tablet. Special placement of the score markings readily permit at least either an accurate bisectional fracture or accurate trisectional fracture of the tablet as may be desired for patient consumption.Type: GrantFiled: March 26, 1979Date of Patent: July 29, 1980Assignee: Mead Johnson & CompanyInventors: Michael K. Ullman, Stephen T. David, Claude E. Gallian
-
Patent number: 4186131Abstract: 1-Secondary-amino-3-(1-phenyl and substituted phenyl-5-tetrazolyloxy)-2-propanols are new compounds which are useful as cardiovascular agents having antiarrhythmic and .beta.-adrenergic blocking actions.Type: GrantFiled: March 24, 1978Date of Patent: January 29, 1980Assignee: Mead Johnson & CompanyInventors: William E. Kreighbaum, William T. Comer
-
Patent number: 4182763Abstract: Buspirone hydrochloride is an effective anti-anxiety agent for the palliative treatment of neurotic patients in which symptoms of anxiety are predominant at doses which are without observable effect in either normal individuals or psychotic patients.Type: GrantFiled: May 22, 1978Date of Patent: January 8, 1980Assignee: Mead Johnson & CompanyInventors: George P. Casten, Gordon R. McKinney, Roger E. Newton, E. Crosby Tompkins, John H. Weikel, Jr.
-
Patent number: 4160863Abstract: A novel crystalline monohydrate of 7-[D-.alpha.-amino-.alpha.-(p-hydroxyphenyl)acetamido]-3-methyl-3-caphem-4 -carboxylic acid is prepared and found to be a stable useful form of the cephalosporin antibiotic especially advantageous for pharmaceutical formulations.Type: GrantFiled: February 2, 1978Date of Patent: July 10, 1979Assignee: Bristol-Myers CompanyInventors: Daniel Bouzard, Abraham Weber, Jacques Stemer
-
Patent number: 4159377Abstract: 2-Aminothiophene-3-carboxamides are converted to oxamates or fumaramides by acylation of the amino group. Cyclization yields thieno[2,3-d]pyrimidines which may also be prepared from the corresponding oxazines. Compounds illustrative of those having inhibitory action on the immediate hypersensitivity reaction in mammals are N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]oxamic acid, ethyl 5,6,7,8-tetrahydro-4-oxo-4H-benzothieno[2,3-d][1,3]oxazine-2-carboxylate, and ethyl 3,4-dihydro-6-ethyl-4-oxothieno[2,3-d]pyrimidine-2-carboxylate.Type: GrantFiled: August 22, 1977Date of Patent: June 26, 1979Assignee: Mead Johnson & CompanyInventor: Davis L. Temple, Jr.
-
Patent number: 4140756Abstract: A tablet for controlled release of a water soluble medicament or dietary supplement is comprised of a water insoluble wax-like matrix core containing the water soluble medicament and coated with a permeable erosion resistant polymeric film. The core constitutes 95% or more of the tablet weight.Type: GrantFiled: October 18, 1977Date of Patent: February 20, 1979Assignee: Mead Johnson & CompanyInventor: Claude E. Gallian
-
Patent number: 4091120Abstract: Superior soy protein beverages are prepared by formulation of carbohydrate, fat, or other nutritional ingredients with the liquid retentate of a soy protein ultrafiltration purification process without first recovering the soy protein by precipitation or drying of the retentate. Short-time high-temperature heat treatment of soy protein solution purified by ultrafiltration improves functional and nutritional qualities thereof.Type: GrantFiled: November 15, 1976Date of Patent: May 23, 1978Assignee: Mead Johnson & CompanyInventors: Kenneth C. Goodnight, Jr., Grant H. Hartman, Jr., Robert F. Marquardt
-
Patent number: 4088795Abstract: An oilseed lipid-protein product adapted for food use is prepared by aqueous extraction of fat containing oilseed materials including the ground raw oilseed or full-fat oilseed flour or flake at a pH in excess of the isoelectric range of the protein for the purpose of solubilizing the protein. Insoluble material is removed by centrifugation or filtration, and soluble carbohydrate is removed from the resulting lipid-protein emulsion by membrane filtration.Type: GrantFiled: November 19, 1976Date of Patent: May 9, 1978Assignee: Mead Johnson & CompanyInventors: Kenneth C. Goodnight, Jr., Grant H. Hartman, Jr.
-
Patent number: 4075344Abstract: New 2-substituted-3(2H)-isoquinolones and 2-substituted-3-alkoxyisoquinolines are disclosed. They are orally active hypotensives and peripheral vasodilators with an extended duration of action. Representative embodiments of this invention are 6,7-dimethoxy-2-methyl-1-veratryl-3(2H)-isoquinolone hydrochloride, 2-allyl-6,7-dimethoxy-2-veratryl-3(2H)-isoquinolone hydrochloride, 2-cyclopropyl-6,7-dimethoxy-1-3(2H)-isoquinolone hydrochloride, 2-amino-6,7-dimethoxy-1-veratryl-3(2H)-isoquinolone hydrochloride and 3-ethoxy-6,7-dimethoxy-1-veratrylisoquinoline.Type: GrantFiled: December 22, 1976Date of Patent: February 21, 1978Assignee: Mead Johnson & CompanyInventors: William E. Kreighbaum, William T. Comer